Back
Exelixis
Founded by : Michael M. Morrissey, 1 January 1994
About the Company
Exelixis, Inc. is a biopharmaceutical company based in California that specializes in developing and commercializing small molecule therapies for the treatment of cancer. The company's flagship product, Cabometyx, is a drug used to treat advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). Exelixis has also developed several other cancer treatments that are in various stages of clinical development. The company was founded in 1994 and has since established partnerships with major pharmaceutical companies such as Bristol-Myers Squibb and Genentech. Exelixis has won numerous awards for its innovative cancer treatments and is widely recognized as a leader in the field of oncology.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Exelixis’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Biotechnology
- Sub-Industry: Biotechnology
Videos and Photos
Company Address
1851 Harbor Bay Parkway Alameda, CA 94502 United States
Source : Google maps